ABL (gene)
Top View
- Tyrosine Kinases As Targets for the Treatment of Rheumatoid Arthritis Christina D’Aura Swanson, Ricardo T
- A Selective Small Molecule C-MET Inhibitor, PHA665752, Cooperates with Rapamycin
- Ph.D. Dissertation
- HER2/Neu: an Increasingly Important Therapeutic Target
- REVIEW Signalling by Insulin and IGF Receptors
- Novel Roles of Erbb3 Receptor Tyrosine Kinase in Vesicular Trafficking
- RUNX1T1 Is Overexpressed in Imatinib Mesylate-Resistant Cells
- Identification of Tyrosine 806 As a Molecular Determinant of RET
- Leukemia BCR-ABL Fusion Gene Typing Real Time RT-PCR Kit User
- Role of Non Receptor Tyrosine Kinases in Hematological Malignances and Its Targeting by Natural Products Kodappully S
- T/Null-Cell Lymphoma in Anaplastic Lymphoma Kinase-Positive
- The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
- Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
- Activated C-Abl Tyrosine Kinase in Malignant Solid Tumors
- The Molecular Crosstalk Between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects
- Explaining Why Gleevec Is a Specific and Potent Inhibitor of Abl Kinase
- Novel Therapeutic Options in Anaplastic Large Cell Lymphoma: Molecular Targets and Immunological Tools
- Srching for the Substrates of Src